home / stock / shief / shief quote
Last: | $0.022 |
---|---|
Change Percent: | 0.0% |
Open: | $0.022 |
Close: | $0.022 |
High: | $0.022 |
Low: | $0.022 |
Volume: | 1,015 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.022 | $0.022 | $0.022 | $0.022 | $0.022 | 1,015 | 05-02-2024 |
$0.0566 | $0.016 | $0.0566 | $0.0566 | $0.0135 | 136,000 | 04-30-2024 |
$0.0192 | $0.0192 | $0.0192 | $0.02 | $0.019 | 1,269,822 | 04-15-2024 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 125,000 | 04-09-2024 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 10,000 | 03-26-2024 |
$0.027 | $0 | $0.027 | $0 | $0 | 49 | 03-22-2024 |
$0.027 | $0.0275 | $0.027 | $0.0275 | $0.027 | 60,000 | 03-21-2024 |
$0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 5,000 | 03-05-2024 |
$0.029 | $0.029 | $0.029 | $0.029 | $0.029 | 10,000 | 03-01-2024 |
$0.029 | $0.029 | $0.029 | $0.029 | $0.029 | 2,400 | 02-29-2024 |
$0.044 | $0.05 | $0.044 | $0.05 | $0.033 | 66,062 | 02-21-2024 |
$0.0835 | $0.0835 | $0.0835 | $0.0835 | $0.0835 | 200 | 12-15-2023 |
$0.077 | $0.077 | $0.077 | $0.077 | $0.077 | 8,650 | 12-13-2023 |
$0.064 | $0.075 | $0.064 | $0.075 | $0.064 | 326,450 | 12-06-2023 |
$0.072 | $0.072 | $0.072 | $0.072 | $0.072 | 200 | 11-09-2023 |
$0.074 | $0 | $0.074 | $0 | $0 | 60,000 | 10-20-2023 |
$0.074 | $0.074 | $0.074 | $0.074 | $0.074 | 100,000 | 10-19-2023 |
$0.1 | $0.1 | $0.1 | $0.1 | $0.1 | 130,000 | 09-28-2023 |
$0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 120,000 | 09-19-2023 |
$0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 50,000 | 09-18-2023 |
News, Short Squeeze, Breakout and More Instantly...
Shield Therapeutics PLC Company Name:
SHIEF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty pharmaceutical company Shield Therapeutics. Davison gives an overview of what readers can expect from the note, highli...
(NewsDirect) Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner after a busy week for the commercial stage pharmaceutical company, which included the release of its interim results and the announcement of a major fundraise. He highlights the succes...
(NewsDirect) Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on Shield Therapeutics PLC, following the release of new prescription data from the commercial-stage specialty pharmaceutical company for its iron deficiency treatment Accruf...